Skip to main content
Equibles

Squarepoint Ops LLC

Position in HAE — Haemonetics Corp

CIK 1642575 NEW YORK, NY
Back to HAE Full portfolio

Position in HAE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,459,300
+$4,809,023 QoQ
Shares Held
86,124
+194.1% QoQ
Ownership
0.189%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 329 holders
Holding Since
Mar 2020
16 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in HAE Over Time

Shares Held

Position Value (USD)

Derivatives in HAE

reported options exposure · as of Sep 30, 2025
CallValue
$0
CallShares
0
PutValue
$891,942
PutShares
18,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $531,520,593 across 64 Medical Devices names. HAE ranks #10 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MDT
Medtronic plc
 2,166,735 $169,503,679
2 ABT
Abbott Laboratories
 867,886 $78,751,975
3 BSX
Boston Scientific Corp
 1,624,929 $69,351,969
4 PEN
Penumbra Inc
 138,413 $43,703,904
5 PODD
Insulet Corp
 267,642 $40,748,494
6 GEHC
GE HealthCare Technologies Inc.
 446,431 $28,576,048
7
418,660 $10,416,260
8 STE
STERIS plc
 41,898 $8,822,461

All Filings in HAE

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,459,300 86,124
2026-03-31 $1,650,277 29,281
2025-09-30 $8,447,324 173,314
2025-09-30 $891,942 18,300
2025-03-31 $14,700,068 231,315
2024-12-31 $1,462,594 18,732
2024-12-31 $952,576 12,200
2024-06-30 $688,148 8,318
2024-03-31 $3,661,258 42,897
2023-12-31 $979,688 11,457
2022-03-31 $416,683 6,591
2021-12-31 $1,010,305 19,048
2021-06-30 $313,674 4,707
2021-03-31 $2,339,202 21,072
2020-12-31 $1,127,887 9,498
2020-09-30 $2,433,664 27,893
2020-06-30 $8,722,517 97,393
2020-03-31 $4,148,347 41,625